Strains high in CBD target the same receptors in the brain that pharmaceuticals can to treat anxiety and stress, and no side effects.

When you have anxiety, feelings of fear and worry become extreme and can even be disabling. Anxiety is different from stress in that the fear remains even in the absence of a negative stimulus.

Unfortunately, conventional treatments don’t always alleviate all symptoms of anxiety. Cannabidiol (CBD), however, could potentially be a safe and effective treatment for anxiety disorders and has shown great promise in clinical and pre-clinical studies.

CBD is a phytocannabinoid found in the Cannabis plant. Unlike THC, CBD does not have psychoactive effects and is being investigated for a number of therapeutic applications, including anxiety disorders.

CBD interacts with several receptors that are known to regulate fear and anxiety responses in the brain, such as: the cannabinoid receptor CB1, the serotonin 5-HT1A receptor, and the transient receptor potential vanilloid type 1 receptor (TRPV1). The exact mechanisms by which CBD interacts with these receptors and helps to improve the symptoms of anxiety is called an “anxiolytic” effect.

These mechanisms are not yet well understood and are the subject of active areas of research. Imaging studies of the brain have shown that CBD affects activity levels of different areas of the brain that are known to play a role in modulating anxiety and fear. Whatever the mechanisms, the effectiveness of CBD and its relative lack of serious side effects mean that it is a promising therapy for various anxiety disorders.

The 5-HT1A receptor is a common target for anti-anxiety pharmaceuticals. The receptor is found at neurons within the brain, where it acts as a post-synaptic receptor that promotes control of anxiety and moderates the brain’s response to stress and panic. CBD may bind directly to this receptor, thereby playing an active role in helping the brain to cope with anxiety.

Research indicates that CBD could also play an indirect role by binding to a different part of the receptor and promoting the binding of other molecules that reduce anxiety and stress.  In fact, CBD showed similar efficacy to the anti-anxiety drug ipsapirone (which also targets the 5-HT1A receptor) in treating patients with social anxiety disorder (SAD).

In both animal and human studies, moderate doses of CBD were found to have the greatest effect on anxiety. For example, volunteers free from anxiety disorders participating in a stress test known as a “test of public speaking in a real situation” (TPSRS) had lower anxiety levels, both physiologically and psychologically, when they took a median dose of CBD (as opposed to a low or a high dose).

CBD has been shown, in numerous human and animal studies, to effectively reduce the symptoms of anxiety and allow the brain to recover its ability to deal with chronic stress and fear.

Originally published: Rxleaf Christine Kielhorn PHD